v3.25.4
DEBT AND CREDIT FACILITIES (Tables)
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below:
December 31, 2025December 31, 2024
Fair ValueCarrying ValueFair ValueCarrying Value
7.003% Senior Notes due 2035 (Fontana) (1)
$100,165 $99,224 $— $— 
5.950% Senior Notes due 2035 (DaVinci) (2)
310,182 296,972 — — 
5.800% Senior Notes due 2035
523,945 493,770 — — 
5.750% Senior Notes due 2033
786,518 743,009 755,693 742,068 
3.600% Senior Notes due 2029
391,708 396,966 376,816 396,051 
3.450% Senior Notes due 2027
297,474 299,260 290,070 298,765 
3.700% Senior Notes due 2025 (3)
— — 299,550 299,908 
4.750% Senior Notes due 2025 (DaVinci) (2) (4)
— — 149,363 149,897 
Total senior notes2,409,992 2,329,201 1,871,492 1,886,689 
Medici Revolving Credit Facility (5)
— — — — 
Total debt$2,409,992 $2,329,201 $1,871,492 $1,886,689 
(1)RenaissanceRe owns a noncontrolling economic interest in its joint venture Fontana. Because RenaissanceRe controls a majority of Fontana’s issued voting shares, the consolidated financial statements of Fontana are included in the consolidated financial statements of RenaissanceRe. RenaissanceRe has not provided any financial or other support to Fontana that it was not contractually required to provide. RenaissanceRe’s financial exposure to Fontana is limited to its investment in Fontana’s shares and counterparty credit risk arising from reinsurance transactions.
(2)RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions.
(3)The 3.700% Senior Notes due 2025 were repaid in full at maturity on April 1, 2025.
(4)The 4.750% Senior Notes due 2025 (DaVinci) were repaid in full at maturity on May 1, 2025.
(5)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. On December 18, 2025, the Medici Revolving Credit Facility was terminated.
Schedule of Aggregate Amount of Maturities Related to the Company's Debt Obligations
The following table sets forth the scheduled maturity of the Company’s aggregate amount of its debt obligation reflected on its consolidated balance sheet at December 31, 2025:
2026$— 
2027300,000 
2028— 
2029400,000 
2030— 
After 20301,650,000 
Unamortized discount and debt issuance expenses(20,799)
 $2,329,201 
  
Schedule of Credit Facilities
The outstanding amounts issued or drawn under each of the Company’s significant credit facilities are set forth below:
At December 31, 2025Issued or Drawn
Revolving Credit Facility (1)
$— 
Medici Revolving Credit Facility (2)
— 
Bilateral Letter of Credit Facilities
Secured
206,515 
Unsecured
322,271 
$528,786 
(1)At December 31, 2025, no amounts were issued or drawn under this facility.
(2)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. On December 18, 2025, the Medici Revolving Credit Facility was terminated.